Order results by:
Issue | Title | |
Vol 16, No 3 (2023) | Clinical and economic assessment of feasibility of using quadritherapy in patients with reduced ejection fraction chronic heart failure in medical organizations of the Moscow Region | Abstract similar documents |
A. D. Ermolaeva, T. N. Ermolaeva, K. A. Kokushkin | ||
"... Region (MR). Material and methods. Clinical and economic analysis of combined standard therapy ..." | ||
Vol 16, No 1 (2023) | Principles of medical care standards development based on clinical guidelines | Abstract similar documents |
Yu. A. Ledovskikh, S. N. Tishkina, G. I. Pirova, E. V. Semakova, V. V. Omelyanovskiy | ||
"... the changing requirements for the development of medical care standards and the current standard form ..." | ||
Vol 16, No 4 (2023) | Pharmacoeconomic analysis of using empegfilgrastim for the treatment of early and locally advanced HER2+ breast cancer in the Russian Federation | Abstract similar documents |
M. V. Zhuravleva, K. A. Kokushkin, E. A. Luchinin, E. V. Luchinina, T. R. Kameneva, E. V. Kuznetsova, V. S. Krysanova, E. V. Makarova, L. G. Zhukova | ||
"... ” regimen, considering possible subsequent adjuvant therapy with trastuzumab emtansine or trastuzumab within ..." | ||
Vol 15, No 4 (2022) | Possibilities of physical therapy and electrophysical modalities in the complex therapy of pneumonia | Abstract similar documents |
D. I. Korabelnikov, V. V. Grigoryev, О. V. Efimova | ||
"... the effectiveness of pneumonia therapy is the widespread introduction of physical therapy (PT) and electrophysical ..." | ||
Vol 16, No 1 (2023) | Efficiency of Levilimab in patients with moderate and severe COVID-19 | Abstract similar documents |
Yu. M. Gomon, V. V. Strizheletsky, I. G. Ivanov, Yu. E. Balykina, M. V. Ermolyev, A. S. Kolbin, M. V. Livshits, T. A. Usmanova, A. M. Fakhrutdinova, Yu. S. Konstantinova, A. P. Gubanov | ||
"... (6% in the Levilimab group and 10% in the standard therapy group; odds ratio (OR) 1.71; 95 ..." | ||
Vol 15, No 4 (2022) | Medical rehabilitation of patients with menopausal syndrome and surgical menopause: contribution of magnesium deficiency correction | Abstract similar documents |
D. V. Blinov, А. G. Solopova, Е. Е. Achkasov, G. К. Bykovshchenko, D. А. Petrenko | ||
"... cancer, is a characteristic trend of the 21st century. Part of them receive menopausal hormone therapy ..." | ||
Vol 16, No 2 (2023) | Pharmacoeconomic analysis of antiretroviral therapy regimes in the Syrian Arab Republic | Abstract similar documents |
Yu. Sh. Gushchina, А. Yu. Abramov, Y. J. Haitham | ||
"... funding in the Syrian Arab Republic (SAR), pharmacoeconomic study of antiretroviral therapy (ART) regimens ..." | ||
Vol 16, No 3 (2023) | Retrospective pharmacoeconomic study of antibiotic therapy in community-acquired pneumonia | Abstract similar documents |
A. A. Taube, T. V. Alexandrova, O. A. Demidova, M. V. Zhuravleva | ||
"... (CAP) include the empirical prescription of antibiotic therapy (ABT) – beta-lactams, fluoroquinolones ..." | ||
Vol 16, No 3 (2023) | Efficacy of alectinib in comparison with lorlatinib in patients with ALK-positive non-small cell lung cancer: pharmacoeconomic study | Abstract similar documents |
A. S. Kolbin, Yu. M. Gomon, M. A. Proskurin, Yu. E. Balykina | ||
"... system: the costs of drug therapy, detecting and relieving adverse events, palliative care. A Markov ..." | ||
Vol 16, No 3 (2023) | An open-label, controlled trial of the clinical effects of Laennec® in patients with nonalcoholic steatohepatitis or cirrhosis | Abstract similar documents |
M. Imawari, M. Nagase, I. Yu. Torshin, O. A. Gromova | ||
"... years). In the therapy group (n=17), patients received Laennec® HPH (4 ml intravenous drip infusion ..." | ||
Vol 16, No 4 (2023) | Development of approaches to the evaluation of pharmacotherapy effectiveness for chronic hepatitis C | Abstract similar documents |
I. A. Narkevich, E. A. Tsitlionok | ||
"... Objective: to analyse the consumption pattern of antiviral therapy (AVT) for chronic hepatitis C ..." | ||
Vol 16, No 3 (2023) | Updated pharmacoeconomic analysis of atesolizumab efficiency compared with other PD-1 inhibitors in patients with advanced non-small cell lung cancer after chemotherapy | Abstract similar documents |
S. K. Zyryanov, I. N. Dyakov | ||
"... provided with PD-1/ PD-L1 inhibitors in the second and third lines of therapy with atezolizumab ..." | ||
Vol 16, No 2 (2023) | Improving the model of payment for medical care for chronic viral hepatitis C in the framework of the implementation of the Program of State Guarantees of Free Provision of Medical Care to Citizens for 2023 and for the planned period of 2024–2025 | Abstract similar documents |
V. V. Omelyanovskiy, I. A. Zheleznyakova, A. V. Zuev, O. S. Plakhotnik, O. A. Volkova, L. M. Davydova, G. V. Trifonova, E. V. Semakova, E. A. Prokhorovich, A. S. Volkova | ||
"... ) in adults were published that did not contain interferon drug therapy regimens. Current therapy of chronic ..." | ||
1 - 13 of 13 Items |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)